IGC Pharma Inc (IGC)
0.508
-0.03
(-6.27%)
USD |
NYAM |
May 01, 16:00
0.5236
+0.02
(+3.07%)
After-Hours: 20:00
IGC Pharma Cash from Financing (Quarterly): -0.001M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.001M |
| September 30, 2023 | 2.859M |
| June 30, 2023 | -0.001M |
| March 31, 2023 | -0.001M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.102M |
| June 30, 2022 | -0.001M |
| March 31, 2022 | -0.001M |
| December 31, 2021 | -0.001M |
| September 30, 2021 | 3.418M |
| June 30, 2021 | 0.726M |
| March 31, 2021 | 14.16M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -0.05M |
| June 30, 2020 | 0.58M |
| March 31, 2020 | -0.077M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.018M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -0.007M |
| December 31, 2018 | 21.92M |
| September 30, 2018 | 5.75M |
| June 30, 2018 | -0.067M |
| March 31, 2018 | 1.297M |
| December 31, 2017 | 1.574M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.5108M |
| June 30, 2017 | 0.3332M |
| March 31, 2017 | 0.8286M |
| December 31, 2016 | -0.4403M |
| September 30, 2016 | 0.57M |
| June 30, 2016 | -0.2508M |
| March 31, 2016 | 1.278M |
| December 31, 2015 | -0.0179M |
| September 30, 2015 | -0.6592M |
| June 30, 2015 | 0.4101M |
| March 31, 2015 | 0.0777M |
| December 31, 2014 | -0.0385M |
| September 30, 2014 | 0.2627M |
| June 30, 2014 | 2.598M |
| March 31, 2014 | 1.240M |
| December 31, 2013 | 0.3962M |
| September 30, 2013 | 0.0999M |
| June 30, 2013 | 0.0001M |
| March 31, 2013 | 0.033M |
| December 31, 2012 | 0.0198M |
| September 30, 2012 | -0.0339M |
| June 30, 2012 | 0.0088M |
| March 31, 2012 | -0.634M |
| December 31, 2011 | 0.0082M |
| September 30, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.077M
Minimum
Mar 2020
14.16M
Maximum
Mar 2021
1.144M
Average
--
Median
Jun 2019
Cash from Financing (Quarterly) Benchmarks
| CEL-SCI Corp | 4.048M |
| AIM ImmunoTech Inc | 0.147M |
| NovaBay Pharmaceuticals Inc | -0.026M |
| Protalix BioTherapeutics Inc | 0.00 |
| Palatin Technologies Inc | 4.974M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.587M |
| Cash from Investing (Quarterly) | -0.061M |
| Free Cash Flow | -6.55M |
| Free Cash Flow Per Share (Quarterly) | -0.0263 |
| Free Cash Flow to Equity (Quarterly) | -1.673M |
| Free Cash Flow to Firm (Quarterly) | -1.674M |
| Free Cash Flow Yield | -23.01% |